Neonatal hTSH FEIA Plus

Neonatal hTSH FEIA Plus Specification

Function
Hospital Use

Color
Multicolor

Technology
Modern

Use
Medical Use

Application
For Hospital amd Clinic Purpose

Portable
Yes

Condition
New

Neonatal hTSH FEIA Plus Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
1 Piece Per Week

Delivery Time
1-6 Week

Main Domestic Market
All India

About Neonatal hTSH FEIA Plus

Labsystems Diagnostics' Neonatal hTSH FEIA Plus is a fluorometric enzyme immunoassay for the quantitative determination of human thyroid stimulating hormone (hTSH, human thyrotropin) in blood samples dried on filter paper as a primary test for screening of babies for congenital hypothyroidism (CH).

overview

hTSH is eluted from dried blood disks. It simultaneously forms a sandwich between the solid phase, coated with an antibody that recognizes a subunit of hTSH and a second antibody derived against another subunit of hTSH, which is labeled with horseradish peroxidase (HRP).

Technical Specifications

61 99 882, Grade 903, 5 strip plates (12x8), 480 wells
61 99 883, Grade 903, 10 strip plates (12x8), 960 wells
61 99 880, Grade 903, 10 solid plates, 960 wells

Benefits

Minimal background
Good stability
Good agreement with CDC samples
Calibrated against the latest international references (WHO and ISNS)

Advanced Neonatal Thyroid Screening

Neonatal hTSH FEIA Plus brings precision to early thyroid disorder screening in newborns. Its advanced immunoassay technology ensures accurate and timely detection of hTSH levels, helping physicians initiate early interventions if congenital hypothyroidism is detected. Designed for ease of use in both hospital and clinic settings, this device ensures high reliability and quick results.

Portable and Efficient Design

With its compact and portable design, the Neonatal hTSH FEIA Plus is perfect for busy hospital environments and clinics. Healthcare professionals can conveniently transport and operate this device across various departments. Its multicolor interface streamlines workflow, making neonatal screenings efficient and reducing wait times for critical diagnostic decisions.

FAQs of Neonatal hTSH FEIA Plus:

Q: How does the Neonatal hTSH FEIA Plus function in a medical setting?

A: The Neonatal hTSH FEIA Plus operates by utilizing immunoassay technology to quantitatively measure hTSH in neonatal blood samples, aiding hospitals and clinics in the early detection of congenital thyroid disorders.

Q: What are the main benefits of using the Neonatal hTSH FEIA Plus for hospitals and clinics?

A: The primary benefits include accurate and timely screening of hTSH levels, portability for flexible use across departments, and advanced technology that ensures reliable results with minimal manual intervention.

Q: When should the Neonatal hTSH FEIA Plus be employed in neonatal care?

A: This device is best utilized shortly after birth, as part of routine newborn screening protocols, to ensure any thyroid issues are detected as early as possible for prompt treatment.

Q: Where can the Neonatal hTSH FEIA Plus be supplied or installed?

A: We distribute, export, and supply the Neonatal hTSH FEIA Plus across hospitals and clinics throughout India, ensuring easy accessibility to advanced neonatal screening technology.

Q: What is the process for using the Neonatal hTSH FEIA Plus?

A: Healthcare staff collect a small blood sample from the newborn, which is then analyzed using the FEIA Plus device. The instrument provides clear, multicolor-coded results, facilitating easy interpretation by medical professionals.

Q: Is the Neonatal hTSH FEIA Plus suitable for clinics as well as large hospitals?

A: Yes, its modern design and portability make it ideal for both large hospital settings and smaller clinics, providing flexibility and consistency in newborn screening regardless of facility size.

Q: Who is responsible for manufacturing and supplying the Neonatal hTSH FEIA Plus in India?

A: We are recognized as a leading distributor, exporter, manufacturer, and supplier of the Neonatal hTSH FEIA Plus, ensuring availability and support for healthcare facilities across India.